Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies-Reference-Cited by-同舟云学术

Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies

Published:2022-10-26 Issue:5 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Molina Mariano A.¹²^ORCID,Coenen Britt A.¹,Leenders William P. J.³,Andralojc Karolina M.¹,Huynen Martijn A.⁴^ORCID,Melchers Willem J. G.¹^ORCID

Affiliation:

1. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands

2. Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands

3. Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands

4. Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands

Abstract

Cervical cancer is the third leading cause of female cancers globally, resulting in more than 300,000 deaths every year. The majority of all cervical cancers are caused by persistent infections with high-risk human papillomaviruses (hrHPV) that can progress to cancer via a series of premalignant lesions.

Funder

Ruby and Rose Foundation

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.01619-22

Reference142 articles.

1. Bruni L Albero G Serrano B Mena M Gómez D Muñoz J et al. Human papillomavirus and related diseases in the world. Summary report 17 June 2019.

2. The complex relationship between human papillomavirus and cervical adenocarcinoma

3. Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection

4. Organization WH. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020.

5. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model;mBio;2024-06-12

2. Methodological and analytical challenges in microbiome‐HPV association studies;Journal of Medical Virology;2023-11

3. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer;Journal of Translational Medicine;2023-09-21

4. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1;Journal of Virology;2023-08-31

5. Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection;Computational and Structural Biotechnology Journal;2023